Douglas Sawyer

March 14, 2013

Heart failure therapy shows promise in early clinical trial

Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.

By Kathy Whitney
August 2, 2012

VHVI reaches milestone in heart valve procedures

Vanderbilt Heart and Vascular Institute recently performed its 100th transcatheter aortic heart valve-replacement (TAVR) on 91-year-old Murline Westover from Lavinia, Tenn.

By Kathy Whitney
November 14, 2011

My Health Chat: Innovation in Heart Care and Genomic Medicine

By VUMC News and Communications
October 28, 2011

VUMC to launch live video chat series Nov. 9

By VUMC News and Communications
October 21, 2011

Promise of Discovery campaign adds video chat, new story lines

By VUMC News and Communications